Drug Registration and Acceptance

Drug Name

Exact

Active Ingredient

Acceptance No.

Manufacturers

Acceptance Date

Status Date

Classification

Review Status

Drug Type

Submission

Evaluation Conclusion

ATC Category

Special Approval Varieties

Task Type

Major Special Varieties

Sequence No.

Stock Code

Visualized Analysis Export Evaluation Conclusion Evaluation Progress

Acceptance No.	Drug Name	Active Ingredient	Dosage Form	Classification	Submission	Acceptance Date	Manufacturers	Review Status	Status Date	View
A20010080	依托泊苷	etoposide	Active ingredient	Chemical Drugs	New Drug Application	2002-04-27	澳大利亚福尔丁有限公司北京代表处	In Approval		view
A20020011	注射用甲磺酸去铁胺	deferoxamine mesilate	Lyophilized	Chemical Drugs	New Drug Application	2002-09-18	澳大利亚福尔丁有限公司北京代表处	In Approval		view
A20020023	帕米膦酸钠浓缩注射液		Injection	Chemical Drugs	New Drug Application	2004-10-12	澳大利亚福尔丁有限公司北京代表处	In Approval		view
B20010153	顺铂	cisplatin	Active ingredient	Chemical Drugs	Import Drug Application	2001-10-29	澳大利亚福尔丁有限公司北京代表处	Approval Completed-Pending Certificated	2002-01-25	view